Cell & Gene Therapy
Cell & Gene Control Towers
In four strategic locations across the globe, Marken’s state-of-the-art monitoring facilities provide full visibility of all cell and gene therapy shipments anywhere in the world. The Cell and Gene Control Tower is Marken’s latest service investment to further enhance our ability to provide flawless execution and expert support for these ultra-sensitive shipments.
Our Cell and Gene Control Center offers 24/7/365 visibility into cell and gene therapy shipments, enabling improved chain of custody and enhanced quality control to ensure sites and patients are receiving these medicines in an efficient and timely manner.
Our dedicated staff of cell and gene supply chain experts will monitor weather, flight delays, and other potential risks to make critical path decisions and ensure flawless execution of every shipment. Combined with our global network of liquid nitrogen storage facilities and fourteen designated Centers of Excellence for cell and gene therapy logistics across the U.S., Europe, and Asia, Marken’s facilities are strategically located to complete an end-to-end cell and gene therapy supply chain service for our clients.
Only Marken delivers the end-to-end capabilities and expert oversight needed to seamlessly guide your program through each stage of the pharmaceutical journey. Our experts and customer service specialists are available to discuss your cell therapy management needs. Contact us on +1-800-627-5361 (US) or email info@marken.com
Related resources
Marken’s Precision Logistics Accelerate Life-Changing Luxturna Therapy Delivery to Patient in South Korea
5 June 2025
When a South Korean patient needed a life-changing gene therapy, Marken orchestrated an international distribution strategy under the strictest regulatory…
Precision Logistics for Complex Therapies
5 June 2025
Advancements in cell and gene therapies (CGTs) have revolutionized treatment for complex diseases, exemplified by Emily Whitehead’s remarkable journey as…
Precision Logistics: A Patient-First Model for Advanced Therapies
3 June 2025
In this exclusive ISCT TV interview, Marken’s Senior Director, Global Cell and Gene Therapy Operations, Rohin Iyer, PhD, shares how Marken…
Does your supply chain hold up under pressure for high-risk temperature-critical shipments?
28 May 2025
Does your supply chain partner deliver under pressure? In today’s high-stakes healthcare environment, defined by the relentless pace of pharmaceutical…
Scaling Cold Chain Precision Logistics for the Future of Advanced Therapeutics
2 May 2025
Advanced therapies represent a new era in medicine offering potentially curative treatments for previously intractable diseases. However, their complex manufacturing…
Marken’s Precision Logistics Expedites Delivery of Critical Gene Therapies to Japan
17 April 2025
Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss that required continous -80°C…
Precision Logistics: Optimizing the Supply Chain for Advanced Therapies
5 March 2025
Cell and Gene Therapies (CGTs) are revolutionizing medicine by offering long-term remission and even cures for previously untreatable diseases. However,…
Mastering the Advanced Therapy Supply Chain
29 October 2024
The field of Advanced Therapy Medicinal Products (ATMPs) has seen monumental advancements in recent years, offering groundbreaking treatments for a…
Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 2
20 September 2024
Part 2 of our Orchestrating Outcomes for Logistics interview series highlights how building resilience into every link of the supply chain drives precision, progress and patient-centric innovation
Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 1
20 September 2024
To drive supply chain digitalization, it’s essential to leverage data not only to address immediate challenges but to anticipate and prevent disruptions
Marken Delivers Life-Saving Gene Therapy Treatment Over 3,000 Miles From Germany to the UAE in Under 48 Hours
18 September 2024
Marken was tasked with delivering a life-saving gene therapy treatment for a child suffering from Duchenne muscular dystrophy (DMD) in…
Marken seamlessly orchestrates distribution of first commercial CAR-T therapy drug product from USA to Japan
17 October 2023
Marken successfully orchestrated the distribution of the first commercial CAR-T therapy drug product from the USA to a hospital in…
Experience the capabilities of three UPS companies uniting as one. Together, we are Marken UPS Healthcare Precision Logistics.
Login and quick links